ArticleFrontiers in immunology2025
Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study.
Xi Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it